Personalized medicine for pancreatic fistula after pancreatoduodenectomy: Targeting improvement through risk profiling

HPB2.90
Volume: 21, Pages: S36 - S37
Published: Mar 1, 2019
Abstract
Background: Despite having many technical options, most surgeons employ a “one size fits all” management strategy for preventing pancreatic fistula (CR-POPF) following pancreatoduodenectomy (PD). Yet, the risk of CR-POPF development is different in every patient. The 4-element/10-point Fistula Risk Score (FRS) quantitates that risk, which can be segregated into four discrete zones for comparison (Negligible, Low, Moderate, High). More...
Paper Details
Title
Personalized medicine for pancreatic fistula after pancreatoduodenectomy: Targeting improvement through risk profiling
Published Date
Mar 1, 2019
Journal
Volume
21
Pages
S36 - S37
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.